Patent ID: 11959136
Assignee: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 7:
8. The method of claim 7, wherein the oxidizing agent is selected from the group consisting of potassium perruthenate (KRuO4), Cu(II)/2,2,6,6-tetramethylpiperidine--oxyl (TEMPO), tetrapropylammonium perruthenate (TPAP), tetrabutylammonium perruthenate (TBAP), polymer-supported perruthenate (PSP), tetraphenylphosphoniurn ruthenate, copper salts or complexes of 3-carbamoyl-2, 2,5,5-tetramethyl-3-pyrrolin-1-yloxy (3-Carbamoyl-PROXYL), copper salts or complexes of 2-azaadamantane-N-oxyl (AZADO) , and copper salts or complexes of 9-azabicyclo [3.3.1] nonane N′-oxyl (ABNO).